FDA Inspection 1077584 — Aurisco Pharmaceutical Co., Ltd
The FDA completed an inspection of Aurisco Pharmaceutical Co., Ltd on November 30, 2018 in Tiantai, Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tiantai, Taizhou (China)